Aura Biosciences, Inc.(AURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AURA Aura Biosciences, Inc.

交易中 11-22 15:59:17 EST

8.96

-0.07

-0.83%

最高9.17	最低8.92	成交量25.33万
今开9.06	昨收9.03	日振幅2.77%
总市值4.47亿	流通市值3.09亿	总股本4,995万
成交额228.32万	换手率0.74%	流通股本3,447万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AURA","market":"US","secType":"STK","nameCN":"Aura Biosciences, Inc.","latestPrice":8.955,"timestamp":1732309155849,"preClose":9.03,"halted":0,"volume":253341,"delay":0,"floatShares":34465642,"shares":49951466,"eps":-1.721869,"marketStatus":"交易中","marketStatusCode":2,"change":-0.075,"latestTime":"11-22 15:59:17 EST","open":9.06,"high":9.17,"low":8.92,"amount":2283172.680591,"amplitude":0.027685,"askPrice":8.96,"askSize":194,"bidPrice":8.95,"bidSize":2461,"shortable":3,"etf":0,"ttmEps":-1.721869,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1635480000000,"adjPreClose":9.03,"volumeRatio":0.655476,"impliedVol":0.46,"impliedVolPercentile":0.1548},"requestUrl":"/m/hq/s/AURA","defaultTab":"news","newsList":[{"id":"2483207581","title":"Aura Biosciences, Inc.盘中异动 下午盘股价大跌5.22%报9.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483207581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483207581?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:34","pubTimestamp":1731699248,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时34分，Aura Biosciences, Inc.股票出现波动，股价急速下挫5.22%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为3.85%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116033408a23be6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116033408a23be6fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AURA"],"gpt_icon":0},{"id":"2483306195","title":"Aura Biosciences, Inc.2024财年第三财季实现净利润-21.04百万美元，同比减少13.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306195?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686436,"startTime":"0","endTime":"0","summary":"11月16日，Aura Biosciences, Inc.公布财报，公告显示公司2024财年第三财季净利润为-21.04百万美元，同比减少13.67%；其中营业收入为0.00美元，每股基本收益为-0.42美元。从资产负债表来看，Aura Biosciences, Inc.总负债30.67百万美元，其中短期债务3.13百万美元，资产负债比为0.07，流动比率为0.13。机构评级：截至2024年11月16日，当前有7家机构对Aura Biosciences, Inc.目标价做出预测，其中目标均价为22.43美元，其中最低目标价为20.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000322abc5160d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000322abc5160d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA"],"gpt_icon":0},{"id":"2477352476","title":"Aura Biosciences, Inc.盘中异动 股价大跌5.15%报11.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477352476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477352476?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:47","pubTimestamp":1729612037,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时47分，Aura Biosciences, Inc.股票出现波动，股价急速下跌5.15%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223471898e3dceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223471898e3dceb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AURA"],"gpt_icon":0},{"id":"2476900261","title":"BUZZ-Aura Biosciences因膀胱癌药物的早期数据而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2476900261","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476900261?lang=zh_cn&edition=full","pubTime":"2024-10-19 00:24","pubTimestamp":1729268650,"startTime":"0","endTime":"0","summary":"    10月18日 - ** 癌症药物开发商Aura Biosciences的  股价上涨15%至11.84美元** 公司报告了治疗非肌肉浸润性膀胱癌患者的实验性癌症药物bel-sar早期试验的中期数据** Aura 公司称，bel-sar 的耐受性良好，五名低级别疾病患者中有四名对该药物的治疗显示出完全的临床反应，没有肿瘤细胞残留。** 覆盖震旦集团的分析师的平均评级为 \"买入\"；中位数预测值为 22 美元--LSEG ** 包括本交易日涨幅在内，该股今年累计上涨16","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AURA"],"gpt_icon":0},{"id":"2476370572","title":"Aura Biosciences, Inc.股价拉升12.62% 市值涨7254.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476370572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476370572?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:31","pubTimestamp":1729258279,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时31分，Aura Biosciences, Inc.股票出现异动，股价快速上涨12.62%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182131199f4d8920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182131199f4d8920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"gpt_icon":0},{"id":"2476943492","title":"Aura Biosciences, Inc.盘中异动 股价大涨5.28%报10.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476943492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476943492?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:04","pubTimestamp":1729094644,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时04分，Aura Biosciences, Inc.股票出现异动，股价急速上涨5.28%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017000404ab6a9393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017000404ab6a9393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AURA"],"gpt_icon":0},{"id":"2470103839","title":"Aura Biosciences, Inc.盘中异动 大幅拉升5.11%报9.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470103839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470103839?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:18","pubTimestamp":1727450280,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时18分，Aura Biosciences, Inc.股票出现异动，股价快速上涨5.11%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231801ab668705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231801ab668705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AURA"],"gpt_icon":0},{"id":"2470298264","title":"Aura Biosciences, Inc.盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470298264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470298264?lang=zh_cn&edition=full","pubTime":"2024-09-26 00:35","pubTimestamp":1727282114,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日00时35分，Aura Biosciences, Inc.股票出现波动，股价急速下跌5.00%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260035149719ca52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260035149719ca52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"gpt_icon":0},{"id":"2467200010","title":"BUZZ--美国股票走势-金矿矿工、银矿矿工、华纳兄弟发现公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2467200010","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467200010?lang=zh_cn&edition=full","pubTime":"2024-09-13 00:02","pubTimestamp":1726156935,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月12日 - 周四，华尔街股市变化不大，此前火热的生产者物价数据使得美联储小幅降息25个基点的可能性依然存在，而疫苗生产商莫德纳的股价则在不乐观的收入预期之后出现下滑。美东时间11:42，道琼斯工业平均指数  持平于40,842.63点。标普500指数  上涨0.11%，报5560.17点；纳斯达克综合指数  上涨0.34%，报17455.082点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELF","WBD","QLD","SQQQ","USB","LU1023059493.AUD",".IXIC","DXD","FULC","NTGR","SIG","VRDN","HL",".DJI","COIN","NEM","IPG","RYDE","CURV","CDE","DAL","BK4570","RH","SDOW",".SPX","GEV","ALK","VNOM","DOG","AURA","PSQ","GEVO","MNQmain","QID","TQQQ","DOW","DDM","NQmain","MRNA","BK4585","DJX","KR","LOVE","DBI","GILD","ONCT","OXM","UDOW","WMG","MPW"],"gpt_icon":1},{"id":"2466427074","title":"BUZZ--美国股票走势-Fulcrum Therapeutics、Summit Therapeutics、Signet Jewelers","url":"https://stock-news.laohu8.com/highlight/detail?id=2466427074","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466427074?lang=zh_cn&edition=full","pubTime":"2024-09-12 21:19","pubTimestamp":1726147150,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月12日 - 在美联储下周可能降息之前，华尔街期货周四在即将公布经济数据之前走高。美东时间9:08，道指电子盘  上涨0.10%，报40945点。标普500指数小型股  上涨0.12%，报收于5,568点；纳斯达克100指数小型股  上涨0.01%，报收于19,273.5点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4095","LOVE","LENZ","BK4094","BK4203","BK4225","BK4090","LU1242518931.SGD","BK4532","BK4551","BK4139","CURV","LU0979878070.USD","SMMT","BK4501","LU2488822045.USD","ELF","BK4200","LU1559883803.SGD","LU2237438978.USD","VRDN","BK4534","BK4539","LU0053671581.USD","BK4008","BK4007","BK4548","VNOM","BK4533","BK4500","LU1242518857.USD","LU0566484027.USD","BK4585","DOW","USB","MPW","BK4588","BK4504","LU0170899867.USD","BK4213","SIG","ALK","AURA","BK4183","BK4207","FULC","BK4568","IE00BFXG1179.USD","BK4559"],"gpt_icon":1},{"id":"2466588275","title":"BUZZ-癌症治疗中期研究数据公布后，Aura Biosciences 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2466588275","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466588275?lang=zh_cn&edition=full","pubTime":"2024-09-12 19:29","pubTimestamp":1726140564,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月12日 - ** 癌症药物开发商Aura Biosciences   股价盘前上涨8%至9.80美元** 该公司称其治疗药物bel-sar的中期研究显示， (link)，早期脉络膜黑色素瘤患者的肿瘤控制率为80%，这些患者符合晚期研究的条件** 脉络膜黑色素瘤是一种罕见的危及生命的眼部癌症。** 震旦集团称，10 名患者中有 90% 的人在治疗后视力得以保留** 截至上次收盘，该公司股价年累计上涨2.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AURA"],"gpt_icon":0},{"id":"2460501886","title":"Aura Biosciences, Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460501886","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460501886?lang=zh_cn&edition=full","pubTime":"2024-08-20 23:38","pubTimestamp":1724168308,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日23时38分，Aura Biosciences, Inc.股票出现波动，股价急速下跌5.36%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820233828a1d53e82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820233828a1d53e82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"gpt_icon":0},{"id":"2460415402","title":"Aura Biosciences, Inc.2024财年第二财季实现净利润-20.34百万美元，同比减少11.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460415402","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460415402?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824037,"startTime":"0","endTime":"0","summary":"8月17日，Aura Biosciences, Inc.公布财报，公告显示公司2024财年第二财季净利润为-20.34百万美元，同比减少11.15%；其中营业收入为0.00美元，每股基本收益为-0.41美元。从资产负债表来看，Aura Biosciences, Inc.总负债26.83百万美元，其中短期债务2.75百万美元，资产负债比为0.09，流动比率为0.19。机构评级：截至2024年8月17日，当前有6家机构对Aura Biosciences, Inc.目标价做出预测，其中目标均价为20.00美元，其中最低目标价为19.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000610959f2d49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000610959f2d49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA"],"gpt_icon":0},{"id":"2459475700","title":"Aura Biosciences, Inc.盘中异动 大幅上涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459475700","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459475700?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:27","pubTimestamp":1723732043,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时27分，Aura Biosciences, Inc.股票出现波动，股价快速拉升5.53%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815222724ab5ddaa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815222724ab5ddaa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"gpt_icon":0},{"id":"2459109561","title":"Aura Biosciences, Inc.盘中异动 早盘大幅跳水5.15%报7.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459109561","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459109561?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:26","pubTimestamp":1723649205,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时26分，Aura Biosciences, Inc.股票出现异动，股价快速跳水5.15%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814232645ab5db103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814232645ab5db103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"gpt_icon":0},{"id":"2458177516","title":"Aura Biosciences, Inc.盘中异动 股价大跌5.43%报8.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458177516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458177516?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:21","pubTimestamp":1723220506,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时21分，Aura Biosciences, Inc.股票出现波动，股价快速下跌5.43%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.75%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810002146af96d6ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810002146af96d6ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"gpt_icon":0},{"id":"2457772698","title":"Aura Biosciences Inc   预计每股亏损45美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457772698","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457772698?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:20","pubTimestamp":1722871214,"startTime":"0","endTime":"0","summary":"   * Aura Biosciences Inc    预计在8月7日公布截至2024年6月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Aura Biosciences Inc的平均预期是每股亏损45美分。* 华尔街对 Aura Biosciences Inc 的 12 个月目标价中位数为 20.00 美元，高于其上次收盘价 9.24 美元。8月5日 - 以前季度业绩。除非另有说明，所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Aura Biosciences Inc   预计每股亏损45美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURA"],"gpt_icon":0},{"id":"2456743737","title":"Aura Biosciences, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456743737","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456743737?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:08","pubTimestamp":1722524898,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时08分，Aura Biosciences, Inc.股票出现异动，股价急速下挫5.63%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801230819af95644b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801230819af95644b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AURA"],"gpt_icon":0},{"id":"2456416922","title":"Aura Biosciences, Inc.盘中异动 下午盘快速拉升5.18%报10.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456416922","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456416922?lang=zh_cn&edition=full","pubTime":"2024-08-01 03:02","pubTimestamp":1722452536,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日03时02分，Aura Biosciences, Inc.股票出现波动，股价快速拉升5.18%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801030216968225c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801030216968225c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"gpt_icon":0},{"id":"2455066032","title":"Aura Biosciences, Inc.盘中异动 临近午盘股价大跌5.12%报9.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455066032","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455066032?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:46","pubTimestamp":1722267996,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时46分，Aura Biosciences, Inc.股票出现波动，股价大幅跳水5.12%。Aura Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Aura Biosciences, Inc.公司简介：Aura Biosciences Inc 是一家临床阶段的生物技术公司，正在开发精准免疫疗法，用于治疗一系列固体肿瘤，旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729234637941fb8fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729234637941fb8fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aurabiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0943},{"period":"1month","weight":-0.2072},{"period":"3month","weight":0.1897},{"period":"6month","weight":0.2845},{"period":"1year","weight":0.1316},{"period":"ytd","weight":0.0192}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aura Biosciences, Inc.于2009年1月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，利用其新型靶向肿瘤学平台，开发一种针对多种癌症适应症的潜在新护理标准，最初专注于眼科和泌尿科肿瘤学。该公司的专有平台能够使用病毒样颗粒或VLP靶向广泛的实体瘤，这些颗粒可以与药物结合或装载核酸以创建病毒样药物结合物或VDC。AU-011是该公司的第一个VDC候选药物，正在开发用于原发性脉络膜黑色素瘤的一线治疗，这是一种没有药物批准的罕见疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.021567},{"month":2,"riseRate":0.333333,"avgChangeRate":0.039466},{"month":3,"riseRate":0.333333,"avgChangeRate":0.007823},{"month":4,"riseRate":0,"avgChangeRate":-0.104093},{"month":5,"riseRate":0.666667,"avgChangeRate":0.091842},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.023112},{"month":7,"riseRate":0.666667,"avgChangeRate":0.106814},{"month":8,"riseRate":0,"avgChangeRate":-0.137399},{"month":9,"riseRate":0.666667,"avgChangeRate":0.113735},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.07827},{"month":11,"riseRate":0.5,"avgChangeRate":0.044677},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.062115}],"exchange":"NASDAQ","name":"Aura Biosciences, Inc.","nameEN":"Aura Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aura Biosciences, Inc.(AURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aura Biosciences, Inc.(AURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aura Biosciences, Inc.,AURA,Aura Biosciences, Inc.股票,Aura Biosciences, Inc.股票老虎,Aura Biosciences, Inc.股票老虎国际,Aura Biosciences, Inc.行情,Aura Biosciences, Inc.股票行情,Aura Biosciences, Inc.股价,Aura Biosciences, Inc.股市,Aura Biosciences, Inc.股票价格,Aura Biosciences, Inc.股票交易,Aura Biosciences, Inc.股票购买,Aura Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aura Biosciences, Inc.(AURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aura Biosciences, Inc.(AURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}